Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03712
Species: Homo sapiens
Position : chr11:8271697-8279492
Year: 2015
Title: Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: neuroblastoma
PMID:  26560027
MONDO: MONDO:0005072
Cell Source: Neuroblastoma Cell Lines
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Genetic-variant functional analysis; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; RNAi/siRNA/shRNA
About Target Gene
Target gene : LMO1
About TF
TF name : GATA3
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA3 C-MYB transcription factor network pid 87
GATA3 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
GATA3 Factors involved in megakaryocyte development and platelet production reactome 111
GATA3 Glucocorticoid receptor regulatory network pid 85
GATA3 IL27-mediated signaling events pid 26
GATA3 Notch signaling pathway pid 58
GATA3 Regulation of nuclear SMAD2/3 signaling pid 82
GATA3 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
GATA3 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer